MA60150A1 - METHODS OF REDUCING THE RISK OF CARDIOVASCULAR EVENTS IN A SUBJECT - Google Patents
METHODS OF REDUCING THE RISK OF CARDIOVASCULAR EVENTS IN A SUBJECTInfo
- Publication number
- MA60150A1 MA60150A1 MA60150A MA60150A MA60150A1 MA 60150 A1 MA60150 A1 MA 60150A1 MA 60150 A MA60150 A MA 60150A MA 60150 A MA60150 A MA 60150A MA 60150 A1 MA60150 A1 MA 60150A1
- Authority
- MA
- Morocco
- Prior art keywords
- subject
- risk
- reducing
- methods
- cardiovascular events
- Prior art date
Links
- 230000002526 effect on cardiovascular system Effects 0.000 title 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 abstract 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 abstract 1
- 230000007211 cardiovascular event Effects 0.000 abstract 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 abstract 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 abstract 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 abstract 1
- 125000004494 ethyl ester group Chemical group 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Dans divers modes de réalisation, la présente invention concerne des procédés de réduction du risque d'événéments cardiovasculaires chez un sujet sous traitement par statine par l'administration au sujet d'une composition pharmaceutique comprenant environ 1 g à environ 4 g d'éthylester de l'acide eicosapentaénoïque ou d'un dérivé de celui-ci.In various embodiments, the present invention relates to methods of reducing the risk of cardiovascular events in a subject under statin treatment by administering to the subject a pharmaceutical composition comprising about 1 g to about 4 g of ethyl ester. eicosapentaenoic acid or a derivative thereof.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862735670P | 2018-09-24 | 2018-09-24 | |
| PCT/US2019/028553 WO2020068163A1 (en) | 2018-09-24 | 2019-04-22 | Methods of reducing the risk of cardiovascular events in a subject |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA60150A1 true MA60150A1 (en) | 2023-11-30 |
Family
ID=78331208
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA51968A MA51968B1 (en) | 2018-09-24 | 2019-04-22 | Methods of reducing the risk of cardiovascular events in a subject |
| MA60150A MA60150A1 (en) | 2018-09-24 | 2019-04-22 | METHODS OF REDUCING THE RISK OF CARDIOVASCULAR EVENTS IN A SUBJECT |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA51968A MA51968B1 (en) | 2018-09-24 | 2019-04-22 | Methods of reducing the risk of cardiovascular events in a subject |
Country Status (1)
| Country | Link |
|---|---|
| MA (2) | MA51968B1 (en) |
-
2019
- 2019-04-22 MA MA51968A patent/MA51968B1/en unknown
- 2019-04-22 MA MA60150A patent/MA60150A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA51968A1 (en) | 2021-10-29 |
| MA51968B1 (en) | 2022-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA52680A1 (en) | Methods of reducing the need for peripheral arterial revascularization in a subject treated with statins | |
| CL2022000997A1 (en) | Methods to reduce the risk of cardiovascular events in a subject. (application divisional 202100645) | |
| MA50258A1 (en) | METHODS OF REDUCING THE RISK OF A CARDIOVASCULAR EVENT IN A SUBJECT UNDERGOING STATIN TREATMENT | |
| MA40814A1 (en) | Pharmaceutical compositions for combination therapy | |
| JP2019048843A5 (en) | ||
| MA37850A1 (en) | Nep inhibitors for the treatment of diseases characterized by atrial enlargement or atrial remodeling | |
| TNSN08194A1 (en) | SOLID PHARMACEUTICAL COMPOSITIONS CONTAINING PREGABALIN | |
| EA200100872A1 (en) | COMPOSITION VALDEKOKSIBA | |
| MA40768A (en) | MONO OR DI-SUBSTITUTE INDOLE DERIVATIVES AS DENGUE VIRUS REPLICATION INHIBITORS | |
| EA199700267A1 (en) | APPLICATION OF FUMAGILLALL AND ITS DERIVATIVES FOR THE PREPARATION OF ANTIINFECTIVE INTESTINAL PREPARATIONS AND PHARMACEUTICAL COMPOSITION ON THEIR BASIS | |
| MA33295B1 (en) | NEW FORMULATION OF DICLOFENAC | |
| MA39725B1 (en) | Pharmaceutical compositions of therapeutically active compounds | |
| MA47082B1 (en) | Aromatic carboxylic acid amides as bradykinin b1 receptor antagonists | |
| MA40937A (en) | BENZOIC ACID, BENZOIC ACID DERIVATIVES AND OXYMORPHONE HETEROARYLCARBOXYLIC ACID CONJUGATES, MEDICINAL PRODUCTS, THEIR MANUFACTURING AND USE METHODS | |
| MA60150A1 (en) | METHODS OF REDUCING THE RISK OF CARDIOVASCULAR EVENTS IN A SUBJECT | |
| MA39421A (en) | EZRINE DERIVATIVES AND CORRESPONDING PHARMACEUTICAL COMPOSITIONS | |
| MA45202B1 (en) | Pharmaceutical composition comprising a mineralocorticoid receptor antagonist and its use | |
| MA30691B1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING ANTI-CA-125 ANTI-IDIOTYPIC MONOCLONAL ANTIBODY AND ALUMINUM. | |
| FR3050112B1 (en) | USE OF FENOFIBRIC ACID IN THE TREATMENT OF HEPATIC DISEASES | |
| MA47498B1 (en) | Pharmaceutical active principle and use in particular in the prevention and treatment of metabolic disturbances in humans and animals | |
| FR3059236B1 (en) | EXTRACTS FROM PLANTS OF THE GENUS TAGETES AND USES THEREOF | |
| MA29329B1 (en) | AMIDE DERIVATIVES AS ION CHANNEL LIGANDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF | |
| MA41102A (en) | COMPOSITIONS CONTAINING CURCUMIN WITH ENHANCED BIOAVAILABILITY | |
| MA43793B1 (en) | Process for the preparation of solid formulations of mesalazine | |
| EA202190859A1 (en) | WAYS TO REDUCE THE RISK OF CARDIOVASCULAR EVENTS IN A SUBJECT |